References
- SibbaldBRolandMUnderstanding controlled trials. Why are randomised controlled trials important?BMJ199831671262019468688
- RubinDBBayesian inference for causal effects: the role of randomisationAnn Stat1978613458
- BoscoJLSillimanRAThwinSSA most stubborn bias: no adjustment method fully resolves confounding by indication in observational studiesJ Clin Epidemiol2010631647419457638
- FreemantleNMarstonLWaltersKWoodJReynoldsMRPetersenIMaking inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational researchBMJ2013347f640924217206
- Evidence-Based Medicine Working GroupEvidence-based medicine. A new approach to teaching the practice of medicineJAMA199226817242024251404801
- SackettDLRosenbergWMGrayJAHaynesRBRichardsonWSEvidence based medicine: what it is and what it isn’tBMJ1996312702371728555924
- RothwellPMCan overall results of clinical trials be applied to all patients?Lancet19953458965161616197783541
- RothwellPMTreating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretationLancet2005365945417618615639301
- RothwellPMMehtaZHowardSCGutnikovSAWarlowCPTreating individuals 3: from subgroups to individuals: general principles and the example of carotid endarterectomyLancet2005365945525626515652609
- RothwellPMExternal validity of randomised controlled trials: “to whom do the results of this trial apply?Lancet20053659453829315639683
- KentDMNelsonJDahabrehIJRothwellPMAltmanDGHaywardRARisk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trialsInt J Epidemiol20164562075208827375287
- SignorelloLBMclaughlinJKLipworthLFriisSSørensenHTBlotWJConfounding by indication in epidemiologic studies of commonly used analgesicsAm J Ther20029319920511941379
- MiddelburgRAvan de WateringLMvan der BomJGBlood transfusions: good or bad? Confounding by indication, an underestimated problem in clinical transfusion researchTransfusion20105061181118320456689
- StromBLMiettinenOSMelmonKLPostmarketing studies of drug efficacy: when must they be randomized?Clin Pharmacol Ther1983341166861430
- StromBLMethodologic challenges to studying patient safety and comparative effectivenessMed Care20074510 Suppl 2S13S1517909371
- KyriacouDNLewisRJConfounding by indication in clinical researchJAMA2016316171818181927802529
- GreenlandSRobinsJMIdentifiability, exchangeability, and epidemiological confoundingInt J Epidemiol19861534134193771081
- LittleRJRubinDBCausal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approachesAnnu Rev Public Health200021121121145145
- HernánMAA definition of causal effect for epidemiological researchJ Epidemiol Community Health200458426527115026432
- VandenbrouckeJPBroadbentAPearceNCausality and causal inference in epidemiology: the need for a pluralistic approachInt J Epidemiol20164561776178626800751
- VincentJLWe should abandon randomized controlled trials in the intensive care unitCrit Care Med20103810 SupplS534S53821164394
- ConcatoJStudy design and “evidence” in patient-oriented researchAm J Respir Crit Care Med2013187111167117223725613
- ConcatoJWhen to randomize, or “Evidence-based medicine needs Medicine-based evidencePharmacoepidemiol Drug Saf201221Suppl 261222552974
- RothmanKJEpidemiologic methods in clinical trialsCancer1977394 Suppl17711775322841
- UddinMJGroenwoldRHAliMSMethods to control for unmeasured confounding in pharmacoepidemiology: an overviewInt J Clin Pharm201638371472327091131
- VandenbrouckeJPWhen are observational studies as credible as randomised trials?Lancet200436394221728173115158638
- BrennerHBlettnerMControlling for continuous confounders in epidemiologic researchEpidemiology1997844294349209859
- BecherHThe concept of residual confounding in regression models and some applicationsStat Med19921113174717581485057